All News

The SHARE model from the CDC involves personalizing recommendations for patients and their needs, addressing any concerns they may have, and explaining the risks of remaining unvaccinated.

This latest revision introduces a new set of drug criteria, refines the existing ones, and enhances the overall formatting to ensure increased ease of use and clarity for its recommendations.

Controlled substance transfers are occurring at a higher rate as health systems create their own ecosystems to combat medication shortages.

Tune in to this episode of the Independent Rx Forum for a comprehensive update on legal developments and insightful discussions on class action lawsuits and regulatory guidelines from the National Community Pharmacists Association.

Amid pharmacy strikes and ongoing challenges, technicians can identify new opportunities for growth

The therapy sustained IDFS benefit compared with ET alone.

The investigators note that psilocybin’s effectiveness in treating depressive symptoms and the positive reception among patients with cancer are encouraging continued research.

The biosimilars landscape is set to witness significant growth, particularly in therapeutic areas like ophthalmology and immunology, with a focus on blockbuster biologics like Humira, Stelara, and Eylea.

The cost of defending license matters and malpractice claim costs have increased over a 5-year period (2017-2022).

Pharmacists play a vital role in HIV care by addressing social determinants of health, managing complex HIV medication regimens, and providing comprehensive patient counseling.

Tarpeyo is now the first fully FDA-approved treatment for primary immunoglobulin A nephropathy, based on measures of kidney function.

Overtime, children can outgrow food allergies, like milk and eggs—however, children with private insurance are more likely to outgrow allergies than those with public insurance.

The study included data on ventilator-associated pneumonia and nonventilator hospital-acquired pneumonia, finding lower rates associated with daily toothbrushing.

The majority (86.7%) of patients in the study got less than 7 hours of sleep each night.

Comprehensive medication reviews and drug interaction assessments are examples of clinical interventions

The results confirm tebentafusp as a standard of care.

Tune in to this episode of Public Health Matters for a captivating exploration of global public health through the lens of a pharmacist and traveler.

These drugs have interesting mechanisms, unique use, or may support expanded indications in the future.

The pharmacies, which include 8 major chains, were revealed to provide prescription records to law enforcement agencies without court orders or warrants.

The results of the study show the importance of considering neighborhood-level disparities to address and improve medication adherence, according to investigators.

The study authors note that the findings could be significant in future HIV vaccine design and development, as well as new approaches to HIV immunotherapy.

The results found that INT301 met both its primary and secondary endpoints and could be a safe and effective option for individuals that experience food allergies.

Individuals received 4 daily short messages that reminding them to participate in self-care, active engagement, and early intervention for the first 30 days of the study.

Investigators aim to find a substitution for incomplete Freund adjuvant, which is not suitable for use in humans but shows a strong response to antigen-specific systemic immune responses.

Investigators will evaluate prophylactic tocilizumab prior to treatment with teclistamab.

Preclinical data showed that LP-184 shrunk tumors in vivo by more than 90% in just 8 weeks.

The results support perioperative nivolumab as a potential new treatment option.

Language gaps resulted in barriers and underdiagnosing in children with common allergies, limiting support for these patients and their families.

The CMS FAQ ruling is resulting in barriers to care for patients.

This approval makes birch triterpenes the first treatment for wounds associated with junctional epidermolysis bullosa to be approved by the FDA.